Combined treatment with tPA and Chinese herbal medicine for ischemic stroke: is it valuable?
CHMs hold considerable potential as ancillary treatments for tPA, due to their unique advantage of multiple therapeutic effects. Future research should prioritize clinical validation to facilitate the integration of CHMs into modern therapeutic regimens as adjuvants to tPA.
Authors
- Mengjie Xia (ORCID: https://orcid.org/0000-0003-2207-0061)
- Jiejie Guo (ORCID: https://orcid.org/0000-0002-0346-7373)
- Meiqi Cao
- Yue Hu
- Jisheng Zhang
- Xuan Cao
Institutions
- Taizhou First People's Hospital (CN)
- The First People's Hospital of Wenling (CN)
- Wenzhou-Kean University (CN)
- Taizhou University (CN)
Publication Details
- Journal
- Journal of Ethnopharmacology
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1016/j.jep.2026.121242
- Primary Topic
- Traditional Chinese Medicine Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00